as on January 17, 2026 at 2:29 am IST
Day's Low
Day's High
0.37%
Downside
2.88%
Upside
52 Week's Low
52 Week's High
33.05%
Downside
15.73%
Upside
Check Biogen Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$24.1B
EPS (TTM)
15.0143
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.19%
PE Ratio (TTM)
14.99
Industry PE ratio
23.148082191780823
PEG Ratio
4.7591
EBITDA
3.4B
Revenue (TTM)
10.1B
Profit Margin
15.98%
Return On Equity TTM
9.31%
Track how Biogen Inc. P/E has moved over time to understand its valuation trends.
Biogen Inc. in the last 5 years
Lowest (7.78x)
June 30, 2025
Today (14.99x)
January 19, 2026
Industry (23.15x)
January 19, 2026
Highest (18.33x)
June 30, 2023
Today’s Price to Earnings Ratio: 14.99x
Compare market cap, revenue, PE, and other key metrics of Biogen Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $24.1B | -39.96% | 14.99 | 15.98% | |
| BUY | $930.9B | 423.18% | 50.75 | 30.99% | |
| BUY | $378.8B | 91.08% | 161.17 | 4.00% | |
| BUY | $526.8B | 34.33% | 21.15 | 27.26% | |
| BUY | $271.8B | 30.82% | 14.4 | 29.63% |
The Biogen Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Biogen Inc. investment value today
Current value as on today
₹1,22,344
Returns
₹22,344
(+22.34%)
Returns from Biogen Inc. Stock
₹16,933 (+16.93%)
Dollar Returns*
₹5,411 (+5.41%)
Based on 42 analysts
71.43%
Buy
28.57%
Hold
0.00%
Sell
Based on 42 analysts, 71.43% of analysts recommend a 'BUY' rating for Biogen Inc.. Average target price of $191.03
Get share price movements and forecasts by analysts on Biogen Inc..
What analysts predicted
13.97%UPSIDE
Target Price
$191.03
Current Price
$164.35
Analyzed by
42 Analysts
Target
$191.03
Biogen Inc. target price $191.03, a slight upside of 13.97% compared to current price of $164.35. According to 42 analysts rating.
Search interest for Biogen Inc. Stock has increased by 4% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:4% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 14 January
Wed, 07:16 PM
-Biogen's upcoming Q4 earnings expected to show profit decline; analysts predict EPS of $1.72, down 50% year-over-year.
Wed, 10:48 PM
-Biogen's stock fell over 4% after announcing a $222 million pretax charge, impacting net income by $1.26 per share.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 3 years, Eli Lilly And Company has given 29.0% return, outperforming this stock by 70.3%
Against Peers
![]()
In the last 1 year, Johnson & Johnson has given 48.7% return, outperforming this stock by 31.7%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 634.8M → 466.5M (in $), with an average decrease of 26.5% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 2.64B → 2.45B (in $), with an average decrease of 7.2% per quarter
Price Dip
![]()
In the last 7 days, BIIB stock has moved down by -11.4%
| Organisation | Biogen Inc. |
| Headquarters | 225 Binney Street, Cambridge, MA, United States, 02142 |
| Industry | Health Technology |
| CEO | Mr. Christopher A. Viehbacher |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Christopher A. Viehbacher | President, CEO & Director |
Ms. Susan H. Alexander Esq. | Executive VP & Chief Legal Officer |
Dr. Priya Singhal M.D., M.P.H. | Executive VP & Head of Development |
Ms. Robin C. Kramer | Executive VP & CFO |
Mr. Guy Hadari | Chief Information Officer |
Ms. Nicole Murphy | Executive VP and Head of Pharmaceutical Operations & Technology |
Mr. Sean Godbout | Chief Accounting Officer & Global Corporate Controller |
Mr. Tim Power M.B.A., Ph.D. | Head of Investor Relations |
Mr. Adam Keeney Ph.D. | Executive VP & Head of Corporate Development |
Dr. Ginger Gregory Ph.D. | Executive VP & Chief Human Resources Officer |
Biogen Inc. share price today is $164.35 as on at the close of the market. Biogen Inc. share today touched a day high of $169.09 and a low of $163.74.
Biogen Inc. share touched a 52 week high of $190.2 on and a 52 week low of $110.04 on . Biogen Inc. stock price today i.e. is closed at $164.35,which is 13.59% down from its 52 week high and 49.36% up from its 52 week low.
Biogen Inc. market capitalisation is $0.02T as on .
Indian investors can start investing in Biogen Inc. (BIIB) shares with as little as ₹90.879 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹908.79 in Biogen Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Biogen Inc. share’s latest price of $164.35 as on January 17, 2026 at 2:29 am IST, you will get 0.0608 shares of Biogen Inc.. Learn more about
fractional shares .
Biogen Inc. stock has given -39.96% share price returns and 23.93% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?